{
    "Trade/Device Name(s)": [
        "Revogene"
    ],
    "Submitter Information": "Genepoc Inc.",
    "510(k) Number": "K170558",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OOI"
    ],
    "Summary Letter Date": "February 23, 2017",
    "Summary Letter Received Date": "February 24, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [],
    "Analyte(s)": [],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [],
    "Document Summary": "FDA 510(k) summary for Genepoc Revogene instrumentation for clinical multiplex test systems",
    "Indications for Use Summary": "",
    "fda_folder": "Clinical Chemistry"
}